UniProt ID | WWOX_HUMAN | |
---|---|---|
UniProt AC | Q9NZC7 | |
Protein Name | WW domain-containing oxidoreductase | |
Gene Name | WWOX | |
Organism | Homo sapiens (Human). | |
Sequence Length | 414 | |
Subcellular Localization | Cytoplasm . Nucleus . Mitochondrion . Golgi apparatus . Partially localizes to the mitochondria (PubMed:14695174). Translocates to the nucleus upon genotoxic stress or TNF stimulation (By similarity). Translocates to the nucleus in response to TGFB1 | |
Protein Description | Putative oxidoreductase. Acts as a tumor suppressor and plays a role in apoptosis. Required for normal bone development (By similarity). May function synergistically with p53/TP53 to control genotoxic stress-induced cell death. Plays a role in TGFB1 signaling and TGFB1-mediated cell death. May also play a role in tumor necrosis factor (TNF)-mediated cell death. Inhibits Wnt signaling, probably by sequestering DVL2 in the cytoplasm.. | |
Protein Sequence | MAALRYAGLDDTDSEDELPPGWEERTTKDGWVYYANHTEEKTQWEHPKTGKRKRVAGDLPYGWEQETDENGQVFFVDHINKRTTYLDPRLAFTVDDNPTKPTTRQRYDGSTTAMEILQGRDFTGKVVVVTGANSGIGFETAKSFALHGAHVILACRNMARASEAVSRILEEWHKAKVEAMTLDLALLRSVQHFAEAFKAKNVPLHVLVCNAATFALPWSLTKDGLETTFQVNHLGHFYLVQLLQDVLCRSAPARVIVVSSESHRFTDINDSLGKLDFSRLSPTKNDYWAMLAYNRSKLCNILFSNELHRRLSPRGVTSNAVHPGNMMYSNIHRSWWVYTLLFTLARPFTKSMQQGAATTVYCAAVPELEGLGGMYFNNCCRCMPSPEAQSEETARTLWALSERLIQERLGSQSG | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Phosphorylation | --MAALRYAGLDDTD --CCCCCCCCCCCCC | 13.08 | 30266825 | |
12 | Phosphorylation | RYAGLDDTDSEDELP CCCCCCCCCCCCCCC | 40.88 | 26503892 | |
14 | Phosphorylation | AGLDDTDSEDELPPG CCCCCCCCCCCCCCC | 49.38 | 26503892 | |
28 | Ubiquitination | GWEERTTKDGWVYYA CCCEEECCCEEEEEE | 54.34 | - | |
33 | Phosphorylation | TTKDGWVYYANHTEE ECCCEEEEEEECCCC | 7.14 | 21082442 | |
33 (in isoform 4) | Phosphorylation | - | 7.14 | 12514174 | |
48 | Ubiquitination | KTQWEHPKTGKRKRV CCCCCCCCCCCCEEE | 72.34 | - | |
61 | Phosphorylation | RVAGDLPYGWEQETD EEECCCCCCCEEEEC | 42.01 | 12514174 | |
100 (in isoform 7) | Ubiquitination | - | 41.44 | 21906983 | |
100 (in isoform 6) | Ubiquitination | - | 41.44 | 21906983 | |
100 (in isoform 5) | Ubiquitination | - | 41.44 | 21906983 | |
100 (in isoform 3) | Ubiquitination | - | 41.44 | 21906983 | |
100 (in isoform 2) | Ubiquitination | - | 41.44 | 21906983 | |
100 (in isoform 1) | Ubiquitination | - | 41.44 | 21906983 | |
100 | Ubiquitination | TVDDNPTKPTTRQRY ECCCCCCCCCCCCCC | 41.44 | 21906983 | |
111 | Phosphorylation | RQRYDGSTTAMEILQ CCCCCCCCCHHHHHC | 24.89 | - | |
134 | Phosphorylation | VVVTGANSGIGFETA EEEECCCCCCCHHHH | 31.11 | - | |
162 | Phosphorylation | CRNMARASEAVSRIL CCHHHHHHHHHHHHH | 22.12 | - | |
176 | Ubiquitination | LEEWHKAKVEAMTLD HHHHHHHHHHHHHHH | 45.47 | - | |
274 (in isoform 1) | Ubiquitination | - | 50.61 | 21906983 | |
274 (in isoform 2) | Ubiquitination | - | 50.61 | 21906983 | |
274 | Ubiquitination | DINDSLGKLDFSRLS CCCCCCCCCCHHHCC | 50.61 | 2190698 | |
281 | Phosphorylation | KLDFSRLSPTKNDYW CCCHHHCCCCCCHHH | 29.43 | 24719451 | |
284 | Ubiquitination | FSRLSPTKNDYWAML HHHCCCCCCHHHHHH | 51.73 | - | |
287 | Phosphorylation | LSPTKNDYWAMLAYN CCCCCCHHHHHHHHC | 12.40 | 11956080 | |
293 | Phosphorylation | DYWAMLAYNRSKLCN HHHHHHHHCHHHHHH | 13.72 | 18083107 | |
312 | Phosphorylation | NELHRRLSPRGVTSN CHHHHHCCCCCCCCC | 15.67 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of WWOX_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of WWOX_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
Note=Defects in WWOX may be involved in several cancer types. The gene spans the second most common chromosomal fragile site (FRA16D) which is frequently altered in cancers. Alteration of the expression and expression of some isoforms is associated with cancers. However, it is still unclear if alteration of WWOX is directly implicated in cancerogenesis or if it corresponds to a secondary effect. | ||||||
133239 | ||||||
614322 | Spinocerebellar ataxia, autosomal recessive, 12 (SCAR12) | |||||
616211 | Epileptic encephalopathy, early infantile, 28 (EIEE28) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-12 AND SER-14, AND MASSSPECTROMETRY. | |
"Transforming growth factor beta1 signaling via interaction with cellsurface Hyal-2 and recruitment of WWOX/WOX1."; Hsu L.-J., Schultz L., Hong Q., Van Moer K., Heath J., Li M.-Y.,Lai F.-J., Lin S.-R., Lee M.-H., Lo C.-P., Lin Y.-S., Chen S.-T.,Chang N.-S.; J. Biol. Chem. 284:16049-16059(2009). Cited for: FUNCTION, PHOSPHORYLATION AT TYR-33, SUBCELLULAR LOCATION, ANDINTERACTION WITH HYAL2. | |
"Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: roleof Ack1 in polyubiquitination of tumor suppressor Wwox."; Mahajan N.P., Whang Y.E., Mohler J.L., Earp H.S.; Cancer Res. 65:10514-10523(2005). Cited for: PHOSPHORYLATION AT TYR-287 BY TNK2, UBIQUITINATION, MUTAGENESIS OFTYR-287, AND INTERACTION WITH TNK2. | |
"Functional association between Wwox tumor suppressor protein and p73,a p53 homolog."; Aqeilan R.I., Pekarsky Y., Herrero J.J., Palamarchuk A., Letofsky J.,Druck T., Trapasso F., Han S.-Y., Melino G., Huebner K., Croce C.M.; Proc. Natl. Acad. Sci. U.S.A. 101:4401-4406(2004). Cited for: FUNCTION, INTERACTION WITH TP73, DOMAIN, MUTAGENESIS OF TYR-33 ANDTYR-61, PHOSPHORYLATION AT TYR-33, AND SUBCELLULAR LOCATION. |